Body-Powered Implants Could End Battery Replacements in Medical Devices
A comprehensive review evaluates five energy harvesting technologies that convert body heat, motion, and glucose into power for implantable devices.
Summary
This 2025 review from researchers at UCL, CAS Hong Kong, and Shanghai Jiao Tong University examines five emerging technologies designed to replace conventional batteries in implantable medical devices and wearables. The strategies covered include electromagnetic wireless power transfer, ultrasound-based power delivery, piezoelectric harvesting from heartbeats and tissue motion, thermoelectric generators exploiting body heat gradients, and glucose-based biofuel cells. Each approach is assessed for power output, biocompatibility, and clinical readiness. The review highlights that hybrid systems combining spontaneous organ activity with voluntary motion show the strongest near-term clinical translation potential. The IMD market, valued at $26.4 billion in 2023 and projected to reach $46.5 billion by 2030, underscores the urgency of solving battery limitations that currently require costly and risky surgical replacements.
Detailed Summary
The global implantable medical device market reached $26.4 billion in 2023 and is projected to grow at 8.2% CAGR to $46.5 billion by 2030, while the wearables sector hit $115 billion and is expected to exceed $265 billion by 2030. Despite this explosive growth, conventional battery technology remains a critical bottleneck — batteries in pacemakers, deep brain stimulators, and cochlear implants require periodic surgical replacement, imposing risks, costs, and reliability concerns. This review systematically evaluates five alternative energy harvesting strategies capable of powering devices from the body's own energy reservoirs.
Electromagnetic wireless power transfer (WPT) encompasses inductive coupling, far-field RF, magnetically coupled resonant (MCR), and mid-field approaches. A notable example is a smart contact lens hybrid system combining WPT with a zinc–air biobattery, generating over 1.5 V DC at 13.56 MHz to operate LEDs. A mid-field WPT system with a compact 9×13 mm² implantable antenna demonstrated over 5.6 mW of delivered power at 1 W transmitter output through simulated pork muscle tissue. MCR-WPT with closed-loop control further stabilized voltage despite coil displacement, advancing practical wearable integration.
Ultrasound wireless power transfer (US-WPT) offers a distinct advantage: ultrasonic waves penetrate electrically conductive biological tissue without the electromagnetic interference that limits RF approaches. The review details piezoelectric receiver designs — including PVDF and PZT-based transducers — that convert ultrasonic mechanical energy into electricity. US-WPT is considered especially promising for deeply implanted devices such as cochlear implants, though challenges remain around tissue heating, beam alignment, and efficiency over longer distances.
Spontaneous organ activity harvesting — capturing energy from heartbeats and tissue motion — uses piezoelectric, triboelectric, and electromagnetic induction mechanisms. Researchers have demonstrated piezoelectric harvesters integrated into pacemaker leads that extract energy directly from cardiac mechanical motion, with permanent magnet stacks achieving flux densities of 1.43 T. Thermoelectric generators (TEGs), exploiting the Seebeck effect across body-environment thermal gradients using bismuth telluride (Bi₂Te₃) and silicon germanium (SiGe) materials, offer continuous passive power for wearables such as fitness trackers, though conversion efficiency remains constrained by the small temperature differentials available (~2–5°C across skin).
Glucose-based biofuel cells represent perhaps the most elegant solution: enzymatic oxidation of endogenous glucose in blood or interstitial fluid generates electrical current continuously, with particular appeal for diabetic monitoring devices. The review also covers triboelectric nanogenerators (TENGs) for harvesting kinetic energy from voluntary movement. Critically, the authors argue that no single modality will suffice — hybrid systems integrating multiple harvesting mechanisms, adaptive AI-driven power management algorithms, and smart biocompatible materials are the most viable path to clinical translation. They identify the biocompatibility-power density paradox and dynamic coupling efficiency in physiological environments as the field's two most pressing unsolved challenges.
Key Findings
- IMD market valued at $26.4 billion in 2023, projected to reach $46.5 billion by 2030 at 8.2% CAGR, driving urgent need for battery-free power solutions
- Smart contact lens hybrid WPT system generated >1.5 V DC at 13.56 MHz, sufficient to operate red and blue LEDs using a zinc–bilirubin oxidase biobattery
- Mid-field WPT system with 9×13 mm² implantable antenna delivered >5.6 mW of received power at 1 W transmitter output through simulated biological tissue
- Electromagnetic cardiac generator using permanent magnets with 1.43 T flux density successfully converted heartbeat mechanical energy into electrical power via induction
- Smart contact lens antenna operating at 920 MHz and 2.4 GHz achieved power transfer efficiency of −17.85 dB at 12 mm transmitter-to-antenna distance, lighting a micro-LED in saline
- Remote patient monitoring devices grew 25% annually between 2020 and 2023 post-COVID, accelerating demand for self-powered wearable and implantable sensors
- Hybrid systems combining spontaneous organ activity harvesting with voluntary motion identified as having highest clinical translation potential among all strategies reviewed
Methodology
This is a comprehensive narrative and evaluative review article, not a primary clinical study — no patient cohort or randomized design was employed. The authors systematically surveyed published experimental prototypes, simulation studies, and in vivo demonstrations across five energy harvesting modalities. Key prototype data cited includes bench-top electrical measurements, finite element simulation results (e.g., pork muscle tissue models for WPT), and animal model demonstrations. Comparative performance metrics such as power output, transfer efficiency, and voltage generation are drawn from referenced primary studies rather than original experiments conducted by the review authors.
Study Limitations
As a review article, the paper does not present original experimental data, and all performance figures are drawn from heterogeneous primary studies with varying methodologies, making direct comparisons difficult. The authors acknowledge that key challenges — including long-term in vivo biocompatibility, regulatory approval timelines, and real-world power density under physiological variability — remain largely unsolved and are not fully quantified in the reviewed literature. No conflicts of interest are declared by the authors, though institutional affiliations span academic centers in China and the UK with no disclosed industry funding.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
